Executive Committee

Randy Teel, Ph.D.

Chief Business Officer

Dr. Randy Teel serves as Chief Business Officer and is responsible for corporate strategy, business development, investor relations, and communications. On an interim basis, Dr. Teel is also acting as Arvinas’ Chief Financial Officer.

Prior to Arvinas, Dr. Teel was Vice President and Head of Strategy at Alexion Pharmaceuticals, where he was responsible for long-range planning, partnering with the R&D and Commercial organizations as they developed inline and lifecycle management strategies. Dr. Teel also led enterprise risk management and numerous strategic initiatives across the company. Prior to Alexion, Dr. Teel was an Associate Partner at McKinsey & Company, where he advised biopharmaceutical clients on issues in commercial, medical, and development.

Dr. Teel also serves on the board of directors at Oerth Bio, Arvinas’ joint venture with Bayer in agricultural biotechnology.

Dr. Teel received his B.Sc. in Biology at Gonzaga University and his Ph.D. in Immunobiology from Yale University.